Navigation Links
Vasomedical, Inc. to Present Live Webcast at RetailInvestorConferences.com on February 7th
Date:2/6/2013

NEW YORK, Feb. 6, 2013 /PRNewswire/ -- Vasomedical, Inc. ("Vasomedical") (OTC BB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices for noninvasive cardiology including EECP® systems, the gold standard of ECP therapy, announced today that Jun Ma , Ph.D., Chief Executive Officer and President, will present at RetailInvestorConferences.com.

DATE:

February 7, 2013

TIME:

12:00 PM EST

LINK:

www.retailinvestorconferences.com > red "register / watch event now" button

This will be a live, interactive, online event where investors are invited to ask the company questions in real-time - both in the presentation hall as well as the company's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.

It is recommended that investors pre-register to save time and receive event updates.

About Vasomedical, Inc.

Vasomedical, Inc. is a diversified medical technology company specializing in the manufacture and sale of medical devices and in the domestic sale of diagnostic imaging products.  The Company's main proprietary products are EECP® Therapy systems, the gold standard of ECP treatment. The Company operates through three wholly owned subsidiaries: VasoSolutions, Vasomedical Global and VasoHealthcare. VasoSolutions manages and coordinates the design, manufacture and sales of EECP® Therapy systems, and other medical equipment operations; Vasomedical Global operates the Company's China-based subsidiaries; and VasoHealthcare is the operating subsidiary for the exclusive sales represent
'/>"/>

SOURCE Vasomedical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lexicon To Present At The BIO CEO & Investor Conference
2. OncoSec Medical to Present at the 15th Annual BIO CEO & Investor Conference
3. Hospira to Present at Upcoming Investor Conferences
4. Aratana Therapeutics to Present at Two Upcoming Healthcare Conferences
5. Tengion to Present at the BIO CEO & Investor Conference
6. ADVENTRX To Present At The 15th Annual BIO CEO & Investor Conference On February 12
7. BioDelivery Sciences to Present at the 15th Annual BIO CEO and Investor Conference
8. Regulus to Present at Two Upcoming Investor Conferences
9. Matinas BioPharma to Present at the NYC Medical Technology Forum on February 5, 2013
10. Epizyme to Present at Upcoming Conferences in February
11. Novelos Therapeutics To Present At The 15th Annual BIO CEO & Investor Conference On February 11
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 20, 2014 Research and Markets ... "Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and ... report to their offering. A ... and geography) - Size, Share, Global Trends, Company ... and Forecast, 2013 - 2020", suggests that the ...
(Date:8/20/2014)... , August 20, 2014 ... report titled "Monochloroacetic Acid (MCA) Market for Cellulosics, Agrochemicals, ... Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 ... at USD 817.1 million in 2013 and is anticipated ... a CAGR of 3.6% during the forecast period from ...
(Date:8/20/2014)... -- Research and Markets has announced ... Care and Closure Market (Types, Applications, End User ... Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation ... their offering. The new report ... (types, applications, end user and geography) - Size, ...
Breaking Medicine Technology:Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) - Research Report, 2013 - 2020 2Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 2Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 3Global Monochloroacetic Acid (MCA) Market is Expected to Reach USD 1,046.7 million by 2020: Transparency Market Research 4Global Advanced Wound Care and Closure Market (Types, Applications, End User and Geography) - Forecast to 2020 2
... indicates that anti-inflammatory drugs may become a new tool ... leading global cause of death. In investigating a specific ... researchers used the Cardiochip, a gene analysis tool designed ... Center for Applied Genomics at The Children,s Hospital of ...
... March 14, 2012 OncoSec Medical Incorporated ... Medical System (OMS) ElectroOncology therapies to treat solid ... Institute in Santa Monica, CA, and Lakeland Comprehensive ... as enrolling sites, and investigators are screening patients ...
Cached Medicine Technology:Gene Chip, Invented by Children's Hospital of Philadelphia Scientist, Pinpoints New Target to Prevent Heart Disease 2Gene Chip, Invented by Children's Hospital of Philadelphia Scientist, Pinpoints New Target to Prevent Heart Disease 3OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 2OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 3OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 4
(Date:8/20/2014)... Line: Less than 42 percent of women underwent ... the factors associated with foregoing reconstruction included being ... older. , Author: Monica Morrow, M.D., of the ... colleagues. , Background: The Women,s Health and Cancer ... breast reconstruction following a mastectomy. Still, most women ...
(Date:8/20/2014)... deploy Ebola vaccines is now, Free content, The ... to a commentary being published early online today in ... authors from Yale School of Public Health write that ... current Ebola outbreak represent a public health crisis that ... Ebola vaccines have been developed in the last decade, ...
(Date:8/20/2014)... Barbara Bronson Gray ... -- Although it,s extremely rare, colds, flu and other ... elevated risk for stroke in children, a new study suggests. ... a stroke in the United States, said Dr. Heather Fullerton, ... and pediatrics at the University of California, San Francisco Benioff ...
(Date:8/20/2014)... HealthDay Reporter WEDNESDAY, Aug. 20, ... grow may help doctors diagnose and treat the most aggressive ... found that the deadliest skin cancers occur most often on ... history of sun exposure. These lesions also grow quickly ... growth -- called "high mitotic rate" -- is associated ...
(Date:8/20/2014)... Park Cities Pet Sitter , Inc. has announced ... donation drive that benefits the animal shelter and rescue communities. ... with the Humane Society of the United States’ Animal Shelter ... , As part of their participation, Park Cities Pet Sitter ... the Presents 4 Pets drive from their client base, as ...
Breaking Medicine News(10 mins):Health News:Patient perspectives on breast reconstruction following mastectomy 2Health News:News from Annals of Internal Medicine 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 3Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 2Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 3Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 2Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 3Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 4
... Inc.,(NYSE: HSP ), a leading global hospital products ... executive officer, will make,a formal presentation at the Bear ... in New York City. The presentation will be ... Tuesday, Sept. 11, 2007, through a live audiocast on ...
... habits to prevent vision problems , FRIDAY, Aug. 31 (HealthDay ... their back-to-school checklist: an eye check for their children and ... eye strain. , One out of two children spends more ... screen, according to the American Optometric Association (AOA). But, the ...
... and Diabetes-Friendly, Recipes at the 34th ... Kidney Patients Meeting, ST. LOUIS, Aug. 31 ... that Katie will be,conducting a cooking demonstration at the ... St. Louis, Mo. this afternoon for,patients with chronic kidney ...
... (WorldHeart) (Nasdaq: WHRT , TSX: WHT), a ... appointment of,Mr. David Pellone as Vice President, Finance ... CFO, will provide consulting services,through the end of ... with certain,specific projects. Mr. Pellone is an ...
... VANCOUVER, Aug. 31 /PRNewswire-FirstCall/ - QLT USA, Inc., ... TSX: QLT), announced today that the European,approval procedure ... completed. Launch of this formulation in 23 European ... positive decision in each,of the individual countries. The ...
... Calif., Aug. 30 Caregivers at Antelope,Valley Hospital, represented ... their first union contract with Antelope Valley,Hospital. The ... a vote of,92.25 percent YES to 7.04 percent no. ... real gains,for healthcare workers and the patients they care ...
Cached Medicine News:Health News:Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11 2Health News:Computer-Related Eye Strain Not Just for Adults 2Health News:Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease 2Health News:Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease 3Health News:Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease 4Health News:Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease 5Health News:Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease 6Health News:Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease 7Health News:WorldHeart Appoints David Pellone Chief Financial Officer 2Health News:Eligard(R) six-month formulation successfully completes European approval procedure 2Health News:Eligard(R) six-month formulation successfully completes European approval procedure 3Health News:UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West 2
... The 5mm AEM Laparoscopic Instruments incorporate a ... Instruments are shielded and monitored to prevent ... the instrument caused by insulation failure or ... The protective shield built into all AEM ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... The Featured Products ... at Mediflex and are ... modular in regular or ... come equipped with insulation, ...
Medicine Products: